|
N-Nitrosodibenzylamine infusion bags
|
|
0
|
63
|
February 27, 2026
|
|
EMA's Revision of the Acceptance Limit for N-Nitroso-N-desmethyl-diphenhydramine
|
|
1
|
130
|
February 27, 2026
|
|
Navigating the complexities in characterization of NDSRIs using advanced analytical techniques-Pub
|
|
1
|
162
|
February 24, 2026
|
|
NDSRI growth with respect to age
|
|
11
|
374
|
February 23, 2026
|
|
N-Nitroso Metamizole Impurity C
|
|
2
|
162
|
February 20, 2026
|
|
👨💻 Quantitation of N-Nitrosodimethylamine (NDMA) and N-Nitrosophenylephrine (NNPE) in Phenylephrine Hydrochloride (API) by LC-MS/MS
|
|
0
|
261
|
February 7, 2026
|
|
👨💻 N-Nitroso-Propranolol Test Method & Validation Report
|
|
0
|
123
|
February 7, 2026
|
|
👨💻 N-Nitroso-Methylphenidate Test Method and Validation Report
|
|
0
|
107
|
February 7, 2026
|
|
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity Data-Pub
|
|
1
|
197
|
February 5, 2026
|
|
Available Tools for Prediction of Potential Degradation Products from Nitrosation Reactions
|
|
4
|
238
|
February 4, 2026
|
|
N-nitroso-rivaroxaban amide
|
|
7
|
1905
|
February 4, 2026
|
|
TGA updated Established acceptable intake for nitrosamines in medicines on 29 January 2026
|
|
0
|
351
|
January 29, 2026
|
|
Nitrosamine Drug Substance-Related Impurities cause DNA methylation adducts in vitro and in primary hepatocytes upon Cytochrome P450-dependend metabolic activation-Pub
|
|
2
|
224
|
January 29, 2026
|
|
Sufentanil Nitroso impurity standard
|
|
8
|
223
|
January 29, 2026
|
|
Nitrosamine Impurities: The Analytical & Regulatory Roadmap (2024-2025)
|
|
0
|
363
|
January 20, 2026
|
|
Hunt for NDSRIs: Unveiling Hidden Threats with the Novel 15N-Enriched NAP Test-Pub
|
|
2
|
378
|
January 7, 2026
|
|
N-nitrosamides, N-nitrosoureas, Nnitrosoguanidines
|
|
7
|
503
|
December 30, 2025
|
|
Establishing Best Practice for N- Nitrosamine Read-Across and Surrogate Selection
|
|
0
|
154
|
December 22, 2025
|
|
N-Nitroso Abemaciclib
|
|
13
|
618
|
December 22, 2025
|
|
N-Nitroso vonoprazan
|
|
1
|
251
|
December 15, 2025
|
|
Nitrosamines in macrocyclic antibiotics
|
|
2
|
227
|
December 10, 2025
|
|
Issue Regarding Purchase of N-Nitroso N-Desmethyl Rosuvastatin Reference Standard
|
|
5
|
252
|
December 10, 2025
|
|
Issue with Area Drop During N-Nitroso Dorzolamide Method Setup
|
|
3
|
197
|
December 10, 2025
|
|
NDSRI in Pyrathiazine theocolate
|
|
3
|
297
|
December 5, 2025
|
|
WHO Updates on Nitrosamine Impurities
|
|
3
|
639
|
December 3, 2025
|
|
FDA Approves Reformulated Ranitidine - Nitrosamine Impurities - NDMA
|
|
3
|
452
|
November 27, 2025
|
|
𝗡-𝗡𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲 𝗙𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗗𝗿𝘂𝗴 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀: 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗮 𝗕𝗶𝗮𝘀𝗲𝗱, 𝗖𝗼𝗻𝘀𝗲𝗿𝘃𝗮𝘁𝗶𝘃𝗲, 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝗠𝗼𝗱𝗲𝗹
|
|
1
|
331
|
November 26, 2025
|
|
N-Nitrosamine Formation in Pharmaceutical Drug Products: Development and Validation of a Biased, Conservative, Predictive Model-Pub
|
|
4
|
451
|
November 24, 2025
|
|
In Vitro Metabolism Study of NDSRIs
|
|
3
|
275
|
November 20, 2025
|
|
Studies addressing potential bioactivation and genotoxicity liabilities of the N-nitroso derivative of the antidepressant paroxetine-Pub
|
|
0
|
110
|
November 18, 2025
|